SB 202 Connecticut Senate · 2024 Regular Session

AN ACT CONCERNING THE DEPARTMENT OF CONSUMER PROTECTION'S RECOMMENDATIONS REGARDING PRESCRIPTION DRUG CONTROL.

This bill updates Connecticut laws to regulate who can sell hypodermic needles and syringes and how pharmaceutical companies must register their sales representatives. It expands the list of individuals and organizations authorized to purchase needles to include additional medical professionals and specific institutions while maintaining restrictions on sales to the general public. The legislation also requires pharmaceutical marketing firms to annually register with the Department of Consumer Protection and submit updated lists of their employed representatives, with the department making these lists publicly available online. Additionally, the bill clarifies definitions for key terms such as pharmaceutical manufacturers and representatives to ensure consistent enforcement of these regulations.
Bill status signed all 5 stages cleared
Introduction
Feb 2024
Committee Review
Mar 2024
Senate Passage
Apr 2024
House Passage
May 2024
Signed into Law
May 2024
Introduced Feb 22, 2024 Signed May 30, 2024
Floor votes · Senate Apr 30, 2024 · House May 8, 2024

How they voted

351
Passed
Total votes 36
Apr 30, 2024
D Democratic24
24 Yea
100% Yea
R Republican12
11 Yea 1 Nay
91% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
18
Key actions
4
Committee
2
May 30, 2024
Signed into law
SIGNED BY GOVERNOR
upper
May 8, 2024
Lower · Passed
HOUSE PASSED
lower
Apr 30, 2024
Upper · Passed
SENATE PASSED
upper
Mar 7, 2024
Upper · Passed
Joint Favorable Substitute
upper
Feb 22, 2024
Committee
REF. TO JOINT COMM. ON General Law
upper
6 primary · 0 co-sponsors

Sponsors